ketoconazole has been researched along with Astrocytoma, Grade IV in 3 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Herein, we report new quinazoline-urea based compounds with potent cytotoxic activities against TMZ-resistant glioblastoma multiforme (GBM) cells." | 7.81 | Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM). ( Cho, H; Elkamhawy, A; Heo, JC; Kim, HY; Kim, KH; Lee, CO; Nam, DH; Pae, AN; Park, WK; Roh, EJ; Seol, HJ; Viswanath, AN; Yang, H, 2015) |
"Herein, we report new quinazoline-urea based compounds with potent cytotoxic activities against TMZ-resistant glioblastoma multiforme (GBM) cells." | 3.81 | Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM). ( Cho, H; Elkamhawy, A; Heo, JC; Kim, HY; Kim, KH; Lee, CO; Nam, DH; Pae, AN; Park, WK; Roh, EJ; Seol, HJ; Viswanath, AN; Yang, H, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elkamhawy, A | 1 |
Viswanath, AN | 1 |
Pae, AN | 1 |
Kim, HY | 1 |
Heo, JC | 1 |
Park, WK | 1 |
Lee, CO | 1 |
Yang, H | 1 |
Kim, KH | 1 |
Nam, DH | 1 |
Seol, HJ | 1 |
Cho, H | 1 |
Roh, EJ | 1 |
Agnihotri, S | 1 |
Mansouri, S | 1 |
Burrell, K | 1 |
Li, M | 1 |
Mamatjan, Y | 1 |
Liu, J | 1 |
Nejad, R | 1 |
Kumar, S | 1 |
Jalali, S | 1 |
Singh, SK | 1 |
Vartanian, A | 1 |
Chen, EX | 1 |
Karimi, S | 1 |
Singh, O | 1 |
Bunda, S | 1 |
Mansouri, A | 1 |
Aldape, KD | 1 |
Zadeh, G | 1 |
Kast, RE | 1 |
Boockvar, JA | 1 |
Brüning, A | 1 |
Cappello, F | 1 |
Chang, WW | 1 |
Cvek, B | 1 |
Dou, QP | 1 |
Duenas-Gonzalez, A | 1 |
Efferth, T | 1 |
Focosi, D | 1 |
Ghaffari, SH | 1 |
Karpel-Massler, G | 1 |
Ketola, K | 1 |
Khoshnevisan, A | 1 |
Keizman, D | 1 |
Magné, N | 1 |
Marosi, C | 1 |
McDonald, K | 1 |
Muñoz, M | 1 |
Paranjpe, A | 1 |
Pourgholami, MH | 1 |
Sardi, I | 1 |
Sella, A | 1 |
Srivenugopal, KS | 1 |
Tuccori, M | 1 |
Wang, W | 1 |
Wirtz, CR | 1 |
Halatsch, ME | 1 |
1 review available for ketoconazole and Astrocytoma, Grade IV
Article | Year |
---|---|
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Auranofin; Brain Neoplasms | 2013 |
2 other studies available for ketoconazole and Astrocytoma, Grade IV
Article | Year |
---|---|
Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dose-Response Relationship | 2015 |
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-R | 2019 |